R. Brown Vance's most recent trade in Boston Scientific Corp. was a trade of 4,036 Restricted Stock Units done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,036 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,036 | 35,403 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.78 per share. | 01 Jul 2025 | 1,952 | 33,451 (0%) | 0% | 104.8 | 204,531 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 106.42 per share. | 21 May 2025 | 4,826 | 31,367 (0%) | 0% | 106.4 | 513,583 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 95.09 per share. | 21 Apr 2025 | 4,826 | 36,193 (0%) | 0% | 95.1 | 458,904 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 100.85 per share. | 21 Mar 2025 | 4,826 | 41,019 (0%) | 0% | 100.8 | 486,702 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 104.64 per share. | 21 Feb 2025 | 4,826 | 45,845 (0%) | 0% | 104.6 | 504,993 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,515 | 11,515 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Units | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,850 | 50,101 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,850 | 3,702 | - | - | Restricted Stock Units | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,839 | 1,839 | - | - | Restricted Stock Units | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,839 | 51,045 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 51,155 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 895 | 49,206 (0%) | 0% | 106.1 | 94,968 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 890 | 50,155 (0%) | 0% | 106.1 | 94,438 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 484 | 50,671 (0%) | 0% | 106.1 | 51,357 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,442 | 4,328 | - | - | Restricted Stock Units | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,442 | 48,675 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 424 | 48,251 (0%) | 0% | 105.8 | 44,846 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 14,708 | 53,583 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 6,350 | 47,233 (0%) | 0% | 106.0 | 672,973 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 6,456 | 0 | - | - | Performance Share Units | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 6,456 | 40,866 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 1,991 | 38,875 (0%) | 0% | 89.3 | 177,836 | Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2024 | 4,036 | 36,362 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2024 | 4,036 | 4,036 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2024 | 1,952 | 34,410 (0%) | 0% | 76.4 | 149,152 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 32,326 (0%) | 0% | 75.6 | 1,363,606 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 0 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 50,363 (0%) | 0% | 24.5 | 442,808 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 0 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 32,326 (0%) | 0% | 76.0 | 1,140,633 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 47,332 (0%) | 0% | 27.1 | 406,513 | Common Stock | |
| Boston Scientific | Vance Brown R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 1,838 | 31,637 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Brown R. Vance | SVP, GC and Corp. Secretary | 16 Feb 2024 | 1,838 | 3,678 | - | - | Restricted Stock Units | ||
| Boston Scientific | Brown R. Vance | SVP, GC and Corp. Secretary | 16 Feb 2024 | 1,000 | 32,097 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Brown Vance R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 1,000 | 1,000 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance Brown R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 741 | 32,544 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Brown Vance R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 741 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Brown Vance R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 540 | 31,097 (0%) | 0% | 65.8 | 35,543 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2024 | 294 | 31,803 (0%) | 0% | 65.8 | 19,351 | Common Stock | |
| Boston Scientific | R. Brown Vance | SVP, GC and Corp. Secretary | 16 Feb 2024 | 218 | 32,326 (0%) | 0% | 65.8 | 14,349 | Common Stock | |
| Boston Scientific | Brown R. Vance | SVP, GC and Corp. Secretary | 14 Feb 2024 | 1,850 | 5,552 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance Brown R. | SVP, GC and Corp. Secretary | 14 Feb 2024 | 1,850 | 30,428 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Brown R. Vance | SVP, GC and Corp. Secretary | 14 Feb 2024 | 629 | 29,799 (0%) | 0% | 66.0 | 41,483 | Common Stock | |
| Boston Scientific | Vance Brown R. | SVP, GC and Corp. Secretary | 12 Feb 2024 | 15,212 | 15,212 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 12 Feb 2024 | 5,770 | 5,770 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 25 Aug 2023 | 15,750 | 28,578 (0%) | 0% | 50.5 | 795,756 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2023 | 4,036 | 8,072 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2023 | 4,036 | 45,687 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2023 | 1,359 | 44,328 (0%) | 0% | 54.1 | 73,508 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 Feb 2023 | 779 | 41,880 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 Feb 2023 | 779 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 Feb 2023 | 229 | 41,651 (0%) | 0% | 46.2 | 10,587 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 1,838 | 5,516 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 1,838 | 40,440 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 1,000 | 2,000 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 1,000 | 40,872 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 741 | 741 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 741 | 41,319 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 568 | 39,872 (0%) | 0% | 46.5 | 26,401 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 294 | 40,578 (0%) | 0% | 46.5 | 13,683 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2023 | 218 | 41,101 (0%) | 0% | 46.5 | 10,146 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2023 | 923 | 38,925 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2023 | 923 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2023 | 323 | 38,602 (0%) | 0% | 47.3 | 15,275 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 14 Feb 2023 | 19,262 | 19,262 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 14 Feb 2023 | 7,402 | 7,402 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 14 Feb 2023 | 6,456 | 6,456 | - | - | Performance Share Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 02 Oct 2022 | 3,394 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 02 Oct 2022 | 3,394 | 38,999 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 02 Oct 2022 | 997 | 38,002 (0%) | 0% | 38.7 | 38,614 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2022 | 4,035 | 12,108 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2022 | 4,035 | 36,790 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2022 | 1,185 | 35,605 (0%) | 0% | 38.0 | 45,042 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 28 Feb 2022 | 1,019 | 0 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 28 Feb 2022 | 1,019 | 33,055 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 28 Feb 2022 | 300 | 32,755 (0%) | 0% | 44.2 | 13,251 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 Feb 2022 | 779 | 32,266 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 Feb 2022 | 779 | 779 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 Feb 2022 | 230 | 32,036 (0%) | 0% | 42.6 | 9,787 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 17 Feb 2022 | 1,000 | 3,000 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 17 Feb 2022 | 1,000 | 31,292 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 17 Feb 2022 | 741 | 31,701 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 17 Feb 2022 | 741 | 1,482 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 17 Feb 2022 | 332 | 30,960 (0%) | 0% | 42.8 | 14,220 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 17 Feb 2022 | 214 | 31,487 (0%) | 0% | 42.6 | 9,106 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2022 | 21,029 | 21,029 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2022 | 7,354 | 7,354 | - | - | Restricted Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2022 | 923 | 923 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2022 | 923 | 30,615 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 15 Feb 2022 | 323 | 30,292 (0%) | 0% | 44.0 | 14,215 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 02 Oct 2021 | 3,393 | 30,829 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 02 Oct 2021 | 3,393 | 3,394 | - | - | Deferred Stock Units | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 02 Oct 2021 | 1,137 | 29,692 (0%) | 0% | 43.8 | 49,801 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2021 | 16,143 | 16,143 | - | - | Restricted Stock Units |